Comparing the Cost-Effectiveness of Disease-Modifying Drugs for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis
Journal of Managed Care Pharmacy
doi 10.18553/jmcp.2009.15.7.543
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2009
Authors
Publisher
Academy of Managed Care Pharmacy